Literature DB >> 9515065

Lead-induced hypertension. II. Response to sequential infusions of L-arginine, superoxide dismutase, and nitroprusside.

Y Ding1, N D Vaziri, H C Gonick.   

Abstract

Administration of 100 ppm lead acetate daily for 3 months caused hypertension in Sprague-Dawley rats, with reversal by treatment with 2,3-dimercaptosuccinic acid (DMSA) (0.5% for 2 weeks). Animals from each group were infused sequentially in 30-min intervals with saline (S), L-arginine (Arg), Arg+ superoxide dismutase (SOD), S, and sodium nitroprusside (SNP). Baseline mean blood pressure (MBP) was elevated in lead-treated animals (Pb) compared to that in controls(C), returning toward normal after DMSA (105 +/- 2 mmHg, C, vs 149 +/- 2, Pb, and 124 +/- 1, DMSA, P < 0.001). Infusion of Arg caused a fall in MBP in all animals, normalizing the MBP in Pb-treated animals. SNP caused a greater fall in MBP in all groups of animals, normalizing the MBP in Pb. Measurement of urinary nitrite + nitrate (NOx) by chemiluminescence revealed at baseline a reduced level in Pb, restored to normal by DMSA (6.6 +/- 1.5 nmol/min/100 g BW, C, vs 3.3 +/- 1.7, Pb, P < 0.05, vs 5.8 +/- 2.6, DMSA, P = NS). Infusion of arginine increased urinary NOx in all groups, but to a lesser degree in Pb and DMSA. Assay of plasma malondialdehyde (MDA) by HPLC, as a measure of reactive oxygen species (ROS), was elevated at baseline in Pb, reduced by DMSA (3.6 +/- 0.4 mumol/L, Pb, vs 1.9 +/- 0.2, C, and 1.9 +/- 0.3, DMSA, P < 0.01). In the Pb group, SOD resulted in a significant fall in MDA (2.0 +/- 0.3 mumol/L, SOD, vs 3.1 +/- 0.1, Arg, P < 0.01), but no further fall in MBP or increase in urinary NOx. Thus, hypertension in lead-exposed animals is related to both diminished NO and increased ROS. The elevation in MBP can be ameliorated by additional NO through infusion of substrate arginine or by treatment with the ROS scavenger, DMSA. Lead-exposed animals show enhanced MBP sensitivity to the NO donors, Arg and SNP, but no further response to SOD, despite a reduction in MDA to normal. We speculate that lead-induced hypertension may be caused by one species of ROS which enhances vascular reactivity, and that provision of additional NO acts to scavenge the ROS and/or acts directly as a vasodilator.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9515065     DOI: 10.1006/enrs.1997.3796

Source DB:  PubMed          Journal:  Environ Res        ISSN: 0013-9351            Impact factor:   6.498


  16 in total

Review 1.  Mechanisms of lead-induced hypertension and cardiovascular disease.

Authors:  Nosratola D Vaziri
Journal:  Am J Physiol Heart Circ Physiol       Date:  2008-06-20       Impact factor: 4.733

Review 2.  Chelation therapy to prevent diabetes-associated cardiovascular events.

Authors:  Denisse Diaz; Vivian Fonseca; Yamil W Aude; Gervasio A Lamas
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2018-08       Impact factor: 3.243

3.  Oxidative effects of lead in young and adult Fisher 344 rats.

Authors:  N Aykin-Burns; A Laegeler; G Kellogg; N Ercal
Journal:  Arch Environ Contam Toxicol       Date:  2003-04       Impact factor: 2.804

Review 4.  Lead-induced hypertension: role of oxidative stress.

Authors:  Nosratola D Vaziri; Domenic A Sica
Journal:  Curr Hypertens Rep       Date:  2004-08       Impact factor: 5.369

5.  Effect of ascorbic acid supplementation on nitric oxide metabolites and systolic blood pressure in rats exposed to lead.

Authors:  Amani Mohammad; Noroozzadeh Ali; Badalzadeh Reza; Khoshbaten Ali
Journal:  Indian J Pharmacol       Date:  2010-04       Impact factor: 1.200

6.  Lead-Induced Cell Cycle Arrest in Human Liver Carcinoma (HepG2) Cells: Involvement of oxidative stress, p53 and Cyclin A.

Authors:  Clement G Yedjou; Paul B Tchounwou
Journal:  Met Ions Biol Med       Date:  2011

7.  Relation Between Lead Exposure and Trends in Blood Pressure in Children.

Authors:  Justin P Zachariah; Yunfei Wang; Daniel J Penny; Tom Baranowski
Journal:  Am J Cardiol       Date:  2018-09-07       Impact factor: 2.778

8.  Heavy metal poisoning and cardiovascular disease.

Authors:  Eman M Alissa; Gordon A Ferns
Journal:  J Toxicol       Date:  2011-09-08

9.  Associations of Community Water Lead Concentrations with Hemoglobin Concentrations and Erythropoietin-Stimulating Agent Use among Patients with Advanced CKD.

Authors:  John Danziger; Kenneth J Mukamal; Eric Weinhandl
Journal:  J Am Soc Nephrol       Date:  2021-07-15       Impact factor: 14.978

10.  The effect of chelation on blood pressure in lead-exposed children: a randomized study.

Authors:  Aimin Chen; George G Rhoads; Bo Cai; Mikhail Salganik; Walter J Rogan
Journal:  Environ Health Perspect       Date:  2006-04       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.